C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2006
10/25/2006	CN1281617C Method for separating human plasma protein fraction by press filtration process
10/25/2006	CN1281270C Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon
10/24/2006	US7126044 Plant genes conferring resistance to Citrus tristeza virus
10/24/2006	US7126042 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents
10/24/2006	US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006	US7125977 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
10/24/2006	US7125976 Method of screening for agents inhibiting chloride intracellular channels
10/24/2006	US7125975 Derivatized oligonucleotides having improved uptake and other properties
10/24/2006	US7125970 Host cells; drug screening; antigrowth agents
10/24/2006	US7125969 Diagnosis; prognosis; transcription factors
10/24/2006	US7125964 Using magnetic beads conjugated with major histocompatability complex peptides to purify and expand in vitro tumor- and virus-specific killer lymphocytes for use in cell therapy, tissue targeted therapy and engineering
10/24/2006	US7125963 Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
10/24/2006	US7125962 Nucleotide sequences coding membrane protein for use in the treatment of cell proliferation disorders
10/24/2006	US7125961 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/24/2006	US7125959 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
10/24/2006	US7125958 membrane proteins acting as binding ligands to mucopolysaccharide receptors for antigens present on the surfaces of palsmodium infected erythrocytes; drugs; antibodies
10/24/2006	US7125956 Peptide fragment of interleukin 1 beta converting enzyme (ICE) itself as ICE inhibitors; peptide is linked to an agent capable of specifically directing the compound to a cell such as fragment of Antennepedia polypeptide, an antibody, an adjuvant or a cell-specific ligand; neurodegenerative disorders
10/24/2006	US7125850 Growth Arrest and DNA Damage-inducible gene 45 (GADD45); for sensitizing proliferating cells by adminstering antibodies; liposomes
10/24/2006	US7125848 Administering conotoxins
10/24/2006	US7125847 polypeptides isolated from spider venoms, used as antiarrhythmia agents; cardiovascular disorders
10/24/2006	US7125846 Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
10/24/2006	US7125843 Glycoconjugates including more than one peptide
10/24/2006	US7125841 Mutants and heparin for blood disorders
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125838 Peptides containing N-substituted L-amino acids for preventing β-strand association
10/24/2006	US7125720 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance
10/24/2006	US7125719 Polypeptides; transgenic plant; stress tolerance
10/24/2006	US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
10/24/2006	US7125714 Progenitor cell materials and methods
10/24/2006	US7125706 Method for the production and purification of adenoviral vectors
10/24/2006	US7125705 Expression vector for use as tool in genetic engineering and gene therapy
10/24/2006	US7125702 Preparation of an proteolytic enzymatic hydrolysate of a selected soybean storage protein fraction, glycinin, that evidences potent Angiotensin Converting Enzyme inhibitory activity.
10/24/2006	US7125698 Polynucleotides isolated from Lactobacillus rhamnosus, oligonucleotide probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, organisms incorporating them
10/24/2006	US7125696 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
10/24/2006	US7125695 Generating bacterial strain with reversible mutation in gene/s associated with DNA repair; bioreactors and heterologous gene expression
10/24/2006	US7125690 Regulatory nucleotide sequence fro use as tools in controlling heterologous/endogenous transcription; transcriptional regulators and bioreactors
10/24/2006	US7125689 Method for rendering streptokinase less immunogenic to a human
10/24/2006	US7125688 A feline hepatocyte growth factor gene and a 15 base pairs-deleted feline hepatocyte growth factor gene. These genes encode the following protein (a) or (b): a protein having an amino acid sequence shown in SEQ ID NO: 2 or 4; and a protein
10/24/2006	US7125687 Presenilin enhancers assays
10/24/2006	US7125686 Proteins and methods for producing the proteins
10/24/2006	US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
10/24/2006	US7125680 Methods and materials for characterizing and modulating interaction between heregulin and HER3
10/24/2006	US7125678 Protein biopolymer markers predictive of type II diabetes
10/24/2006	US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator
10/24/2006	US7125675 Method for inhibiting tumor invasion or spreading in a subject
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125667 Polymorphic markers of the LSR gene
10/24/2006	US7125666 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody
10/24/2006	US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
10/24/2006	US7125662 Identifying microorganismal nucleotide sequences associated with antibiotic resistance protein for use as components to improve identification of vector transformed cells
10/24/2006	US7125661 Sequences for the detection of Escherichia coli
10/24/2006	US7125658 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
10/24/2006	US7125569 Removal of plasmin(ogen) from protein solutions
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125556 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
10/24/2006	US7125554 Engineered superantigen for human therapy
10/24/2006	US7125551 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
10/24/2006	US7125548 Nucleotide sequences coding microorganismal cistron; for use in detection of microoganismal infection
10/24/2006	CA2342948C Attenuated vaccine for blastomyces dermatitidis
10/24/2006	CA2273549C Diagnostic agents for pancreatic exocrine function
10/19/2006	WO2006110760A2 Compositions and methods for the diagnosis and treatment of tumor
10/19/2006	WO2006110677A2 Gene inactivated mutants with altered protein production
10/19/2006	WO2006110591A2 POP2 NFkB-INHIBITING POLYPEPTIDES, NUCLEIC ACIDS AND METHODS OF USE
10/19/2006	WO2006110344A1 Novel methods for inducing an immune response against human immunodefiency virus
10/19/2006	WO2006110339A1 CELLULAR STANDARDS FOR GLYCATED HEMOGLOBIN AlC DETERMINATION
10/19/2006	WO2006110091A1 Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
10/19/2006	WO2006109943A1 Human protooncogene and protein encoded by same
10/19/2006	WO2006109942A1 Human protooncogene trg and protein encoded therein
10/19/2006	WO2006109941A1 Human cancer suppressor gene, protein encoded therein
10/19/2006	WO2006109855A1 Peptide having food intake stimulating effect and method for screening for the peptide
10/19/2006	WO2006109698A1 Composition comprising genetically engineered erythropoietin
10/19/2006	WO2006109696A1 Composition comprising genetically engineered follicle-stimulating hormone
10/19/2006	WO2006109695A1 Composition comprising genetically engineered haptoglobin
10/19/2006	WO2006109424A1 Dnas encoding protein having function of forming and regulating cellulosic fiber cell wall in tree trunk and promoter dnas of the same
10/19/2006	WO2006109301A2 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
10/19/2006	WO2006109192A2 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
10/19/2006	WO2006109174A2 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
10/19/2006	WO2006109092A1 Conjugate comprising p21 protein for the treatment of cancer
10/19/2006	WO2006109071A2 Vaccine against burkholderia infections
10/19/2006	WO2006108720A2 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
10/19/2006	WO2006108686A2 Bnp agonists
10/19/2006	WO2006108594A1 Peptide synthesis of alpha-helixes on peg resin
10/19/2006	WO2006108590A1 Modified coagulation factor viii with enhanced stability and its derivates
10/19/2006	WO2006108586A2 Polymyxin b analogs for lps detoxification
10/19/2006	WO2006108518A1 Isolated photoprotein gr-bolinopsin and use thereof
10/19/2006	WO2006108455A1 Serum-free cell culture medium for mammalian cells
10/19/2006	WO2006108211A1 Fragments of von willebrand factor a-related protein
10/19/2006	WO2006091824A3 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
10/19/2006	WO2006080837A3 Means and methods for breaking noncovalent binding interactions between molecules
10/19/2006	WO2006078273A3 Methods and compositions for producing recombinant proteins
10/19/2006	WO2006077404A3 Cell adhesion by modified cadherin molecules
10/19/2006	WO2006062685A3 Novel peptides that bind to the erythropoietin receptor
10/19/2006	WO2006050211A3 Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
10/19/2006	WO2006048449A3 Mc4r selective peptides and their use in the treatment of obesity
10/19/2006	WO2005111622A8 Diagnostic assay for trypanosoma cruzi infection
10/19/2006	WO2005097179A3 Stabilised tat antigen and the use thereof for anti-hiv vaccination
10/19/2006	WO2005094569A8 Ion channel
10/19/2006	WO2005092924A8 Rab9a, rab11a, and modulators thereof related to infectious disease
10/19/2006	WO2005089252A3 Methods and compositions for the treatment of obesity
10/19/2006	WO2005081783A3 Method for determination and quantification of radiation or genotoxin exposure

1 ... 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 ... 2916